Exam (elaborations) NURS 6521 WEEK 9 QUIZ 2
A nurse is discussing oprelvekin therapy with a male patient. Which of the following will the nurse tell the patient is the most common adverse effect of the drug? A patient has been scheduled to begin treatment with rituximab for non-Hodgkin’s lymphoma. The nurse who will administer this drug should understand that it targets A patient with a diagnosis of chronic myeloid leukemia has met with her oncologist, who has recommended treatment with the kinase inhibitor imatinib. What route of administration should the nurse explain to the patient? A female patient is prescribed oprelvekin therapy to treat thrombocytopenia. Which of the following should the nurse continuously monitor to determine the efficacy and duration of the oprelvekin therapy?
Geschreven voor
- Instelling
- Walden University
- Vak
- NURS 6521 WEEK 9 QUIZ 2
Documentinformatie
- Geüpload op
- 10 januari 2022
- Aantal pagina's
- 7
- Geschreven in
- 2021/2022
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
a nurse is discussing oprelvekin therapy with a male patient which of the following will the nurse tell the patient is the most common adverse effect of the drug a patient has been scheduled to begi
